CR Bard Inc (BCR)

BCR (NYSE:Health Services)
pos +0.27
Today's Range: 146.36 - 147.52 | BCR Avg Daily Volume: 520,300
Last Update: 09/19/14 - 1:54 PM EDT
Volume: 247,526
YTD Performance: 0.00%
Open: $147.00
Previous Close: $146.88
52 Week Range: $113.52 - $154.16
Oustanding Shares: 74,635,981
Market Cap: 10,895,360,506
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 9 10 11 11
Moderate Sell 1 1 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.95 2.95 2.88 2.88
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
0.00 15.00 28.82
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 3.10 0.12 0.04
Net Income 30.10 0.35 0.11
EPS 38.80 0.58 0.16
Earnings for BCR:
Revenue 3.05B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $2.10 $2.24 $8.31 $9.25
Number of Analysts 10 9 12 12
High Estimate $2.17 $2.27 $8.34 $9.45
Low Estimate $2.07 $2.15 $8.30 $9.00
Prior Year $1.50 $1.42 $5.78 $8.31
Growth Rate (Year over Year) 40.13% 57.67% 43.83% 11.27%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
A wave of M&A in the health sector makes sense.
Jun 18, 2014 | 7:38 AM EDT
BCR was downgraded to Equal Weight from Overweight, Barclays said. Pressure on co due to its exposure to the peripheral vascular space,...
Apr 07, 2014 | 8:19 AM EDT
BCR was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $150 price target. 
Jan 06, 2014 | 8:33 AM EST
BCR was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, as the stock gained 37% in 2013. 
Oct 23, 2013 | 8:14 AM EDT
BCR was upgraded from Neutral to Overweight, Piper Jaffray said. $140 price target. Organic growth profile is improving. 
Oct 23, 2013 | 7:51 AM EDT
BCR was upgraded from Sell to Neutral, Goldman Sachs said. Negative catalysts have been realized. $132 price target.

Buying Stocks by the Basket Real Money Pro($)

These 15 stocks have similar price patterns and technical setups.
For most investors, this simple strategy is the way to go.

C.R. Bard Illustrates a Point Real Money Pro($)

Occasionally there is unusual technical synchronization on multiple timeframes.
Feb 22, 2013 | 8:21 AM EST
BCR was downgraded to Sell from Neutral, Goldman Sachs said. $95 price target. Market giving too much credit for outer eyar revenue/EPS...

Columnist Conversations

The bull channel that has been in place since the late July/early August lows is clearly broken. Two wee...
Alibaba (BABA) is dominating talk on CNBC and the trading floor today and having impacts on the overall market...
As you guys know, I do a lot of work with TD Ameritrade strategists...check out this stat re: BABA At TD Amer...
The action in CAG has been very volatile this week. On Wednesday the stock was dragged down in the earl...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.